middle.news
EVE Launches Dyspro™ Distribution via TeleDocs to Tackle Women’s Health Market
8:30am on Monday 22nd of September, 2025 AEST
•
Healthcare
Read Story
EVE Launches Dyspro™ Distribution via TeleDocs to Tackle Women’s Health Market
8:30am on Monday 22nd of September, 2025 AEST
Key Points
Dyspro™ manufactured at Australian GMP-certified facility
Available for prescription through TeleDocs telehealth network
Targets dysmenorrhoea and endometriosis with large unmet medical needs
Global treatment market expected to exceed USD 20 billion by 2035
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE